Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2009.127894v1, 2009; 10.1373/clinchem.2009.127894
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2009.127894v1
55/8/1568    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cheng, S.-H.
Right arrow Articles by Ng, M. H.-L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, S.-H.
Right arrow Articles by Ng, M. H.-L.

Received on ,
Accepted on ,

Brief Communications

New Testing Approach in HLA Genotyping Helps Overcome Barriers in Effective Clinical Practice

Suk-Hang Cheng 1, Patrick Kwan 2, Ho-Keung Ng 1, Margaret H.-L. Ng 1*

1 Departments of Anatomical & Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR
2 Departments of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR

* To whom correspondence should be addressed. E-mail: margaretng{at}cuhk.edu.hk.

BACKGROUND: Severe and potentially fatal hypersensitivity reactions to drugs, particularly antiepileptics, are clinically unpredictable. Recent evidence has revealed a strong and specific association between the implicated drug, the type of adverse reaction, and the particular HLA genotype. An urgent need exists for rapid diagnosis of HLA status to guide drug prescription; however, traditional HLA genotyping has a long turnaround time, is expensive, and is available only in specialized centers. We tested the feasibility of the loop-mediated isothermal amplification (LAMP)-based approach to detect a specific HLA genotype. As an example, we used B*1502, an HLA allele strongly associated with carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis, and validated the assay's application as a simple, accurate, rapid, and low-cost blood test for use in both clinical and bedside settings.

METHODS: We evaluated B*1502 status with the new LAMP method and compared the results with those obtained by sequence-based typing (SBT) (n = 250) and by sequence-specific primer PCR (SSP-PCR) (n = 200) for 450 samples of DNA (n = 50) and blood (n = 400) from a hematology laboratory.

RESULTS: LAMP results showed 100% concordance with both SBT and SSP-PCR results, confirming that LAMP detection of a specific HLA genotype (B*1502 in this case) is an accurate method. All results were available within 1 h.

CONCLUSIONS: Our study confirmed that the new LAMP method for detecting a specific HLA genotype is simple, inexpensive, accurate, and rapid, and may be of help in overcoming barriers in effective clinical practice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Association for Clinical Chemistry.